Anixa Biosciences, Inc. (ANIX)
3.365
-0.12
(-3.30%)
USD |
NASDAQ |
Aug 31, 16:00
3.365
0.00 (0.00%)
After-Hours: 20:00
Anixa Biosciences Free Cash Flow (Quarterly) : -1.741M for April 30, 2026
Free Cash Flow (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| April 30, 2026 | -1.741M |
| January 31, 2026 | -2.61M |
| October 31, 2025 | -1.255M |
| July 31, 2025 | -1.511M |
| April 30, 2025 | -1.503M |
| January 31, 2025 | -2.904M |
| October 31, 2024 | -0.927M |
| July 31, 2024 | -2.643M |
| April 30, 2024 | -1.456M |
| January 31, 2024 | -2.309M |
| October 31, 2023 | -1.969M |
| July 31, 2023 | -1.445M |
| April 30, 2023 | -0.807M |
| January 31, 2023 | -1.988M |
| October 31, 2022 | -1.593M |
| July 31, 2022 | -1.396M |
| April 30, 2022 | -2.306M |
| January 31, 2022 | -1.197M |
| October 31, 2021 | -1.044M |
| July 31, 2021 | -1.481M |
| April 30, 2021 | -1.242M |
| January 31, 2021 | -1.170M |
| October 31, 2020 | -1.414M |
| July 31, 2020 | -1.291M |
| April 30, 2020 | -1.556M |
| Date | Value |
|---|---|
| January 31, 2020 | -1.930M |
| October 31, 2019 | -1.337M |
| July 31, 2019 | -0.6401M |
| April 30, 2019 | -1.610M |
| January 31, 2019 | -1.330M |
| October 31, 2018 | -1.028M |
| July 31, 2018 | -1.19M |
| April 30, 2018 | -0.7518M |
| January 31, 2018 | -1.342M |
| October 31, 2017 | -0.7526M |
| July 31, 2017 | -1.254M |
| April 30, 2017 | -1.076M |
| January 31, 2017 | -0.744M |
| October 31, 2016 | -0.6849M |
| July 31, 2016 | -0.8182M |
| April 30, 2016 | -1.387M |
| January 31, 2016 | -0.6384M |
| October 31, 2015 | -0.8019M |
| July 31, 2015 | -0.7085M |
| April 30, 2015 | -1.779M |
| January 31, 2015 | 4.598M |
| October 31, 2014 | -0.3621M |
| July 31, 2014 | -0.3373M |
| April 30, 2014 | -0.5078M |
| January 31, 2014 | -1.172M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -181.32M |
| Oncolytics Biotech, Inc. | -8.066M |
| Sangamo Therapeutics, Inc. | -19.30M |
| Sarepta Therapeutics, Inc. | 196.52M |
| Vicapsys Life Sciences, Inc. | -0.0051M |